• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number D132705
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Cardiac Tamponade (2226); Pericarditis (4448)
Event Date 08/07/2023
Event Type  Injury  
Manufacturer Narrative
Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number lot 31051084m and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
During a clinical trial sponsored by bwi, it was reported that a patient underwent repeat/retreatment ablation procedure on (b)(6) 2023 for atrial tachycardia.Patient had a chads2vasc score of 3, and history of hypertension and paroxysmal fibrillation.On (b)(6) 2023, patient experienced cardiac tamponade categorized as severe and serious as defined by in-patient or prolonged hospitalization and medical or surgical intervention to prevent life-threatening illness or injury, or permanent impairment to a body structure or a body function.Patient was admitted to the hospital (b)(6) 2023 and discharged from the hospital (b)(6) 2023.Relationship to study device is causal and relationship to primary study procedure is causal relationship to the repeat/retreatment procedure.The adverse event is expected/anticipated.The outcome is recovering/resolving.Intervention was "pericardial punction" on (b)(6) 2023, patient also experienced pericarditis constrictiva categorized as moderate and serious as defined by prolonged hospitalization with an admission date of (b)(6) 2023.Relationship to study device is probable and relationship to primary study procedure is causal relationship to the repeat/retreatment procedure.The adverse event was expected / anticipated.The outcome is not recovered / resolved.Intervention was medication.On (b)(6) 2023, patient experienced bilateral pneumonia categorized as moderate and not serious.Relationship to study device is not related and relationship to primary study procedure is probable relationship to the repeat/retreatment procedure.The outcome is recovered/resolved with an end date of (b)(6) 2023.Intervention was medication.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious.
 
Manufacturer Narrative
On 27-oct-2023, bwi received additional information indicating that the patient's outcome improved.The initial report started that the patient's cardiac tamponade was in the process of recovering/resolving.The new information indicates that the incident has fully recovered and resolved as of (b)(6) 2023.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17690960
MDR Text Key322740249
Report Number2029046-2023-02004
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835009200
UDI-Public10846835009200
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P030031/S053
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberD132705
Device Lot Number31051084M
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/27/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age66 YR
Patient SexFemale
Patient Weight76 KG
-
-